51³Ô¹ÏÍø

Skip to main content

51³Ô¹ÏÍø commercialization drives $8 billion in impact nationwide

51³Ô¹ÏÍø commercialization drives $8 billion in impact nationwide

Inscripta, Inc., a 51³Ô¹ÏÍø spinout company, is a global leader in automated, CRISPR-based gene editing.

Activities led by Venture Partners at 51³Ô¹ÏÍø, the university’s commercialization arm, generated an economic impact of $8 billion nationally and $5.2 billion in the state of Colorado over the last five years, according to a report from the Leeds School of Business, reflecting a four-fold increase in impact since the previous report published in 2019. 

  • Notable findings from the report on fiscal years 2018-2022 include: 
  • The economic impact on the national economy included an estimated 39,000 jobs. 
  • Commercialization of licenses and startups spanned 36 states and 26 countries. 
  • Agreements generated $20.1 million in revenue for 51³Ô¹ÏÍø in licensing technology. 
  • 51³Ô¹ÏÍø inventors and researchers received $45.4 million in commercialization-specific grants. 
  • Startups founded on 51³Ô¹ÏÍø technology generated $3 billion in capital funding.

Collaboration + support
Venture Partners at 51³Ô¹ÏÍø